Literature DB >> 21487599

Synthesis and physicochemical characterization of new squalenoyl amphiphilic gadolinium complexes as nanoparticle contrast agents.

Mohammad Othman1, Didier Desmaële, Patrick Couvreur, Luce Vander Elst, Sophie Laurent, Robert N Muller, Claudie Bourgaux, Estelle Morvan, Thierry Pouget, Sinda Lepêtre-Mouelhi, Philippe Durand, Ruxandra Gref.   

Abstract

A family of novel amphiphilic gadolinium chelates was successfully obtained by coupling the hydrophilic DOTA ligand [1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane] to squalenoyl moieties. Thanks to the self-assembling properties of their squalenoyl lipophilic moieties, all these derivatives were able to form, without any adjuvant, micellar or liposome-like supramolecular nanoassemblies, endowed with high relaxivities (r(1) = 15-22 mM(-1) s(-1) at 20 MHz and 37 °C). The remarkably high payloads of Gd(3+) ions reached 10 to 17 wt %. Moreover, one of these derivatives interacted with human serum albumin (HSA) forming mixed micelles, which induced a remarkable increase in relaxivity. Liposome-like structures were obtained when the Gd(3+) complex of DOTA was coupled to two squalene units. These liposomal structures were characterized by a high loading of Gd(3+) (about 74,000 gadolinium ions per particle of 100 nm). The supramolecular architecture of these nano-objects has been investigated by electron microscopy and small-angle X-ray scattering. Squalenoylation of gadolinium derivatives offers a platform to conceive contrast agents (CAs) in mild conditions (no toxic solvents, no surfactants, no energy input). These new amphiphilic gadolinium chelates could also find potential applications in theranostics, by forming mixed systems with other squalenoylated drugs, or to delineate blood vessels owing to the interaction with HSA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21487599     DOI: 10.1039/c1ob00015b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  6 in total

Review 1.  Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

Authors:  Houshang Amiri; Kolsoum Saeidi; Parvin Borhani; Arash Manafirad; Mahdi Ghavami; Valerio Zerbi
Journal:  ACS Chem Neurosci       Date:  2013-09-26       Impact factor: 4.418

2.  Deciphering the Biochemical Pathway and Pharmacokinetic Study of Amyloid βeta-42 with Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Using Systems Biology Approach.

Authors:  Aman Chandra Kaushik; Ajay Kumar; Vivek Dhar Dwivedi; Shiv Bharadwaj; Sanjay Kumar; Kritika Bharti; Pavan Kumar; Ravi Kumar Chaudhary; Sarad Kumar Mishra
Journal:  Mol Neurobiol       Date:  2017-05-06       Impact factor: 5.590

3.  IMPROVED SYNTHESIS OF 10-(2-ALKYLAMINO-2-OXOETHYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID DERIVATIVES BEARING ACID-SENSITIVE LINKERS.

Authors:  Bhumasamudram Jagadish; Tarik J Ozumerzifon; Sue A Roberts; Gabriel B Hall; Eugene A Mash; Natarajan Raghunand
Journal:  Synth Commun       Date:  2014       Impact factor: 2.007

Review 4.  Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.

Authors:  Sabrina Valetti; Simona Mura; Barbara Stella; Patrick Couvreur
Journal:  J Nanobiotechnology       Date:  2013-12-10       Impact factor: 10.435

5.  A Scalable Method for Squalenoylation and Assembly of Multifunctional 64Cu-Labeled Squalenoylated Gemcitabine Nanoparticles.

Authors:  Samantha T Tucci; Jai W Seo; Hamilton Kakwere; Azadeh Kheirolomoom; Elizabeth S Ingham; Lisa M Mahakian; Sarah Tam; Spencer Tumbale; Mo Baikoghli; R Holland Cheng; Katherine W Ferrara
Journal:  Nanotheranostics       Date:  2018-09-05

6.  Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents.

Authors:  Simone Rodrigues Silva; Érica Correia Duarte; Guilherme Santos Ramos; Flávio Vinícius Crizóstomo Kock; Fabiana Diuk Andrade; Frédéric Frézard; Luiz Alberto Colnago; Cynthia Demicheli
Journal:  Bioinorg Chem Appl       Date:  2015-08-10       Impact factor: 7.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.